Evidence map›Paper›PMID 40488998›Full record

ReviewTopics in current chemistry (Cham)2025

Breaking Bonds, Breaking Paradigms: Critical Insights into Inner-Sphere C(sp

Peng Zhang, Youjia Hao, Ke Shi, Zixin Deng, Jiangtao Gao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peng Zhang *Key BioAI Synthetica Lab for Natural Product Drug Discovery, National and Local United Engineering Laboratory of Natural Biotoxin, College of Bee and Biomedical Sciences, Fujian Agriculture and Forestry University, Fuzhou, 350002, China.
Youjia Hao *Key BioAI Synthetica Lab for Natural Product Drug Discovery, National and Local United Engineering Laboratory of Natural Biotoxin, College of Bee and Biomedical Sciences, Fujian Agriculture and Forestry University, Fuzhou, 350002, China.
Ke Shi *Key BioAI Synthetica Lab for Natural Product Drug Discovery, National and Local United Engineering Laboratory of Natural Biotoxin, College of Bee and Biomedical Sciences, Fujian Agriculture and Forestry University, Fuzhou, 350002, China.
Zixin DengState Key Laboratory of Microbial Metabolism, Joint International Laboratory On Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China.
Jiangtao GaoKey BioAI Synthetica Lab for Natural Product Drug Discovery, National and Local United Engineering Laboratory of Natural Biotoxin, College of Bee and Biomedical Sciences, Fujian Agriculture and Forestry University, Fuzhou, 350002, China. jgaotao@gmail.com.

Funding

National Key Research and Development Program of China 2021YFA0910500
6 · The paper itself

Abstract

This review systematically analyzes recent advances in transition metal-catalyzed carbene and nitrene insertion into unactivated aliphatic C(sp

Indexed as

MethaneTransition ElementsCatalysiscarbeneMethaneTransition ElementsCarbene and nitrene insertionInner-sphere pathwayRegioselectivityTransition metal-catalyzedUnactivated C(sp3)–H bonds

Identifiers

PMID40488998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.